Diabetes and the risk of tuberculosis: A neglected threat to public health?

Chronic Illness

Volumn 3, Issue 3, 2007, Pages 228-245

  Stevenson, Catherine R ^a   Critchley, Julia A ^b   Forouhi, Nita G ^a   Roglic, Gojka ^c   Williams, Brian G ^c   Dye, Christopher ^c   Unwin, Nigel C ^b  

^a MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Association; Case control; Cohort; Diabetes; Tuberculosis

Indexed keywords

TRACE ELEMENT;

AGE DISTRIBUTION; CORRELATION ANALYSIS; DATA EXTRACTION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; EVALUATION; GENDER; GLYCEMIC CONTROL; HUMAN; IMMUNE SYSTEM; IRON OVERLOAD; KIDNEY FAILURE; MEDLINE; MICROANGIOPATHY; MORTALITY; PUBLIC HEALTH; PUBLIC HEALTH PROBLEM; REVIEW; RISK FACTOR; SAMPLE SIZE; SOCIAL STATUS; STATISTICAL SIGNIFICANCE; TREATMENT FAILURE; TUBERCULOSIS; VITAMIN DEFICIENCY; ADULT; AGED; FEMALE; MALE; MIDDLE AGED; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS; FEMALE; HUMANS; MALE; MIDDLE AGED; PUBLIC HEALTH; RISK ASSESSMENT; TUBERCULOSIS;

EID: 35148847322     PISSN: 17423953     EISSN: 17459206     Source Type: Journal    
DOI: 10.1177/1742395307081502     Document Type: Review

References (80)

1. Morton R. Phthisiologia: or a treatise of consumptions, London: Smith and Walford, 1694.
2. Cooper DA, Boucot KR, Dillon ES, Meier P., Richardson R. Tuberculosis among diabetics: the Philadelphia survey. Trans Annu Meet Natl Tuberc Assoc 1951 ; 47: 175 - 81.
3. Ferrara MA The tuberculous diabetic patient. N Engl J Med 1952 ; 246: 55 - 6.
4. Brock BL The diabetic patient with tuberculosis. Lancet 1957 ; 77: 238 - 42.
5. Department of Health. Stopping tuberculosis in England: An Action Plan from the Chief Medical Officer. London: Department of Health, 2004: 1 - 25.
6. Tuberculosis Coalition for Technical Assistance. International Standards for Tuberculosis Care (ISIT). The Hague: Tuberculosis Coalition for Technical Assistance, 2006.
7. Grange JM, Zumla A. The global emergency of tuberculosis: what is the cause? J R Soc Health 2002 ; 122: 78 - 81.
8. Ramachandran A. Epidemiology of diabetes in India - three decades of research. J Physicians India 2005 ; 53: 34 - 8.
9. Unwin N., Alberti KG Chronic non-communicable diseases. Ann Trop Med Parasitol 2006 ; 100: 455 - 64.
10. Deeks JJ, Dinnes J., D'Amico R., et al. Evaluating non-randomised intervention studies. Health Technol Assess 2003 ; 7: 1 - 173.
11. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of healthcare interventions. J Epidemiol Community Health 1998 ; 52: 377 - 84.
12. Dickersin K. Systematic reviews in epidemiology: why are we so far behind? Int J Epidemiol 2002 ; 31: 6 - 12.
13. Kim SJ, Hong YP, Lew WJ, Yang SC, Lee EG Incidence of pulmonary tuberculosis among diabetics. Tuber Lung Dis 1995 ; 76: 529 - 33.
14. Ponce-De-Leon A., Garcia-Garcia Md Mde L., Garcia-Sancho MC, et al. Tuberculosis and diabetes in southern Mexico. Diabetes Care 2004 ; 27: 1584 - 90.
15. Dyck RF, Klomp H., Marciniuk DD, et al. The relationship between diabetes and tuberculosis in Saskatchewan. Can J Public Health 2007 ; 98: 55 - 9.
16. Pablos-Mendez A., Blustein J., Knirsch CA The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health 1997 ; 87: 574 - 9.
17. Perez A., Brown HS 3rd, Restrepo BI. Association between tuberculosis and diabetes in the Mexican border and non-border regions of Texas. Am J Trop Med Hyg 2006 ; 74: 604 - 11.
18. Shetty N., Shemko M., Vaz M., D'Souza G. An epidemiological evaluation of risk factors for tuberculosis in South India: a matched case control study. Int J Tuberc Lung Dis 2006 ; 10: 80 - 6.
19. Alisjahbana B., van Crevel R., Sahiratmadja E., et al. Diabetes mellitus is strongly associated with tuberculosis in Indonesia. Int J Tuberc Lung Dis 2006 ; 10: 696 - 700.
20. Decode Study Group. Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European centres. Diabetologia 1999 ; 42: 647 - 54.
21. Qiao Q., Nakagami T. Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts. Diabetologia 2000 ; 43: 1470 - 5.
22. Jick SS, Lieberman ES, Rahman MU, Choi HK Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Rheum 2006 ; 55: 19 - 26.
23. Coker R., McKee M., Atun R., et al. Risk factors for pulmonary tuberculosis in Russia: case-control study. BMJ 2006 ; 332: 85 - 7.
24. Shaikh MA, Singla R., Khan NB, Sharif NS, Saigh MO Does diabetes alter the radiological presentation of pulmonary tuberculosis. Saudi Med J 2003 ; 24: 278 - 81.
25. Restrepo BI, Fisher-Hoch SP, Crespo JG, et al. Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect 2007 ; 135: 483 - 91.
26. Guler M., Unsal E., Dursun B., Aydin O., Capan N. Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis. Int J Clin Pract 2007 ; 61: 231 - 5.
27. Bacakoglu F., Basoglu OK, Cok G., Sayiner A., Ates M. Pulmonary tuberculosis in patients with diabetes mellitus. Respiration 2001 ; 68: 595 - 600.
28. Mboussa J., Monabeka H., Kombo M., Yokolo D., Yoka-Mbio A, Yala F. Course of pulmonary tuberculosis in diabetics. Rev Pneumol Clin 2003 ; 59: 39 - 44.
29. Singla R., Khan N., Al-Sharif N., Ai-Sayegh MO, Shaikh MA, Osman MM Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients. Int J Tuberc Lung Dis 2006 ; 10: 74 - 9.
30. Moran A., Harbour DV, Teeter LD, Musser JM, Graviss EA Is alcohol use associated with cavitary disease in tuberculosis? Alcohol Clin Exp Res 2007 ; 31: 33 - 8.
31. Wang JY, Lee LN, Hsueh PR Factors changing the manifestation of pulmonary tuberculosis. Int J Tuberc Lung Dis 2005 ; 9: 777 - 83.
32. Perez-Guzman C., Torres-Cruz A., VillarrealVelarde H., Salazar-Lezama MA, Vargas MH Atypical radiological images of pulmonary tuberculosis in 192 diabetic patients: a comparative study. Int JTuberc Lung Dis 2001 ; 5: 455 - 61.
33. Pérez-Guzmán C., Torres-Cruz A., VillarrealVelarde H., Vargas MH Progressive age-related changes in pulmonary tuberculosis images and the effect of diabetes. Am J Respir Crit Care Med 2000 ; 162: 1738 - 40.
34. Nissapatorn V., Kuppusamy I., Jamaiah I., Fong MY, Rohela M., Anuar AK Tuberculosis in diabetic patients: a clinical perspective. Southeast Asian J Trop Med Public Health 2005 ; 36 (Suppl 4). 213 - 20.
35. Morsy AM, Zaher HH, Hassan MH, Shouman A. Predictors of treatment failure among tuberculosis patients under DOTS strategy in Egypt. East Mediterr Health J 2003 ; 9: 689 - 701.
36. Kameda K., Kawabata S., Masuda N. Follow-up study of short course chemotherapy of pulmonary tuberculosis complicated with diabetes mellitus. Kekkaku 1990 ; 65: 791 - 803.
37. Nijland HM, Ruslami R., Stalenhoef JE, et al. Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes. Clin Infect Dis 2006 ; 43: 848 - 54.
38. Yurteri G., Sarac S., Dalkilic O., Ofluoglu H., Demiroz OF Features of pulmonary tuberculosis in patients with diabetes mellitus: a comparative study. Turkish Respir J 2004 ; 5: 5 - 8.
39. Bashar M., Alcabes P., Rom WN, Condos R. Increased incidence of multidrug-resistant tuberculosis in diabetic patients on the Bellevue Chest Service, 1987 to 1997. Chest 2001 ; 120: 1514 - 19.
40. Subhash HS, Ashwin I., Mukundan U., et al. Drug resistant tuberculosis in diabetes mellitus: a retrospective study from south India. Trop Doct 2003 ; 33: 154 - 6.
41. Fielder JF, Chaulk CP, Dalvi M., Gachuhi R., Comstock GW, Sterling TR A high tuberculosis case-fatality rate in a setting of effective tuberculosis control: implications for acceptable treatment success rates. Int J Tuberc Lung Dis 2002 ; 6: 1114 - 17.
42. Oursler KK, Moore RD, Bishai WR, Harrington SM, Pope DS, Chaisson RE Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors. Clin Infect Dis 2002 ; 34: 752 - 9.
43. Rao VK, Iademarco EP, Fraser VJ, Kollef MH The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis. Chest 1998 ; 114: 1244 - 52.
44. Luntz GR Management of the tuberculous diabetic; follow-up of 84 cases for one year. BMJ 1957 ; 1: 1082 - 6.
45. Pérez-Guzmán C., Vargas MH, Torres-Cruz A., Pérez-Padilla JR, Furuya MEY, Villarreal-Velarde H. Diabetes modifies the male:female ratio in pulmonary tuberculosis. Int J Tuberculosis Lung Dis 2003 ; 7: 354 - 8.
46. Leung CC, Yew WW, Tam CM, et al. Socioeconomic factors and tuberculosis: a district-based ecological analysis in Hong Kong. Int J Tuberc Lung Dis 2004 ; 8: 958 - 64.
47. Nakatani H., Fujii N., Mori T., Hoshinot H. Epidemiological transition of tuberculosis and future agenda of control in Japan: results of the Ad-Hoc National Survey of Tuberculosis 2000. Int J Tuberc Lung Dis 2002 ; 6: 198 - 207.
48. Bhopal R., Hayes L., White M., et al. Ethnic and socio-economic inequalities in coronary heart disease, diabetes and risk factors in Europeans and South Asians. J Public Health Med 2002 ; 24: 95 - 105.
49. Evans JM, Newton RW, Ruta DA, MacDonald TM, Morris AD Socio-economic status, obesity and prevalence of type 1 and type 2 diabetes mellitus. Diabet Med 2000 ; 17: 478 - 80.
50. Kamadjeu RM, Edwards R., Atanga JS, Kiawi EC, Unwin N., Mbanya JC Anthropometry measures and prevalence of obesity in the urban adult population of Cameroon: an update from the Cameroon Burden of Diabetes Baseline Survey. BMC Public Health 2006 ; 6: 228.
51. Aspray T., Mugusi F., Rashid S., et al. Rural and urban differences in diabetes prevalence in Tanzania: the role of obesity, physical inactivity and urban living. Trans R Soc Trop Med Hygiene 2000 ; 94: 637 - 44.
52. Chukanova VP, Sergeev AS, Pospelov LE, Sobkin AL Epidemiological and immunogenetic analysis of tuberculosis and diabetes mellitus association. Probl Tuberk 2000 ; 4: 11 - 14.
53. Feleke Y., Abdulkadir J., Aderaye G. Prevalence and clinical features of tuberculosis in Ethiopian diabetic patients. East Afr Med J 1999 ; 76: 361 - 4.
54. Olmos P., Donoso J., Rojas N., et al. Tuberculosis and diabetes mellitus: a longitudinal-retrospective study in a teaching hospital. Rev Med Chil 1989 ; 117: 979 - 83.
55. Tamura M., Shirayama R., Kasahara R., et al. A study on relation between active pulmonary tuberculosis and underlying diseases. Kekkaku 2001 ; 76: 619 - 24.
56. Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias C., Smith H. Infection and diabetes: the case for glucose control. Am J Med 1982 ; 72: 439 - 50.
57. Wang CH, Yu CT, Lin HC, Liu CY, Kuo HP Hypodense alveolar macrophages in patients with diabetes mellitus and active pulmonary tuberculosis. Tubercle Lung Dis 1999 ; 79: 235 - 42.
58. Abe T., Iinuma Y., Ando M., et al. NRAMP1 polymorphisms, susceptibility and clinical features of tuberculosis. J Infect 2003 ; 46: 215 - 20.
59. Tsukaguchi K., Yoneda T., Yoshikawa M., et al. Case study of interleukin-1 beta, tumor necrosis factor alpha and interleukin-6 production by peripheral blood monocytes in patients with diabetes mellitus complicated by pulmonary tuberculosis. Kekkaku 1992 ; 67: 755 - 60.
60. Tsukaguchi K., Okamura H., Ikuno M., et al. The relation between diabetes mellitus and IFN-gamma, IL-12 and IL-10 productions by CD4 + alpha beta T cells and monocytes in patients with pulmonary tuberculosis. Kekkaku 1997 ; 72: 617 - 22.
61. Tsukaguchi K., Okamura H., Matsuzawa K., et al. Longitudinal assessment of IFN-gamma production in patients with pulmonary tuberculosis complicated with diabetes mellitus. Kekkaku 2002 ; 77: 409-13.
62. Kawakami K. Tuberculosis in diabetes mellitus: aggravation and its immunological mechanism. Kekkaku 2003 ; 78: 717 - 22.
63. Yamashiro S., Kawakami K., Uezu K., et al. Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocininduced diabetes mellitus infected with Mycobacterium tuberculosis. Clin Exp Immunol 2005 ; 139: 57 - 64.
64. Koziel H., Koziel MJ Pulmonary complications of diabetes mellitus. Pneumonia. Infect Dis Clin North Am 1995 ; 9: 65 - 96.
65. Yuan FH, Guang LX, Zhao SJ Clinical comparisons of 1,498 chronic renal failure patients with and without tuberculosis. Renal Failure 2005 ; 27: 149 - 53.
66. Wen Y., Sahni A., Rea CA, Zhang XH, Khokher MA, Singh BM Differential antioxidant status among Indo-Asians compared with caucasians with and without diabetes. Wolverhampton Diabetes Research Group. Diabetes Care 2000 ; 23: 254 - 5.
67. Ramachandran G., Santha T., Garg R., et al. Vitamin A levels in sputum-positive pulmonary tuberculosis patients in comparison with household contacts and healthy 'normals'. Int J Tuberculosis Lung Dis 2004 ; 8: 1130 - 3.
68. Vijayamalini M., Manoharan S. Lipid peroxidation, vitamins C, E and reduced glutathione levels in patients with pulmonary tuberculosis. Cell Biochem Function 2004 ; 22: 19 - 22.
69. Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 2003 ; 89: 552 - 72.
70. Mathieu C., Gysemans C., Giulietti A., Bouillon R. Vitamin D and diabetes. Diabetologia 2005 ; 48: 1247 - 57.
71. Walker AR, Segal I. Iron overload in Sub-Saharan Africa: to what extent is it a public health problem? Br J Nutr 1999 ; 81: 427 - 34.
72. Pickup JC Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004 ; 27: 813 - 23.
73. Takasu N., Yamada T., Miura H., et al. Rifampicin-induced early phase hyperglycemia in humans. Am Rev Respir Dis 1982 ; 125: 23 - 7.
74. Luntz G. Tuberculous diabetics: the Birmingham Regional Service. Lancet 1954 ; 266: 973 - 4.
75. McIntosh A., Hutchinson A., Home PD, et al. Clinical guidelines and evidence review for type 2 diabetes: management of blood glucose, Sheffield: ScHARR, University of Sheffield, 2002.
76. National Collaborating Centre for Chronic Conditions. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control., London: Royal College of Physicians, 2006.
77. Raviglione M., Uplekar M. WHO's new Stop TB Strategy. Lancet 2006 ; 367: 952 - 5.
78. World Health Organization. The Stop TB Strategy, Geneva: WHO, 2006.
79. Centers for Disease Control. Reported tuberculosis in the United States, 2003., Atlanta, GA: US Department of Health and Human Services, CDC, 2004.
80. Cegielski JP, McMurray DN The relationship between malnutrition and tuberculosis: evidence from studies in humans and experimental animals. Int J Tuberc Lung Dis 2004 ; 8: 286 - 98.